A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
9/18/2026
BreakingEuropeGlaucomaLaser
Lumibird Medical Launches Astral Contactless SLT Platform with Integrated OCT
France’s Lumibird Medical announced Sept. 12 the launch of the Astral, a contactless selective laser trabeculoplasty (SLT) platform for glaucoma. The device was unveiled at the 2026 congress of the...
9/18/2026
BreakingDeviceGlaucomaRegulation
Balance Ophthalmics Announces 2026 Medicare Pricing for FSYX Pump and Goggles
Balance Ophthalmics reported Aug. 18 that regulators had set 2026 Medicare payment amounts for the FSYX Ocular Pressure Adjusting Pump (OPAP) and associated goggles, effective Oct. 1. The FSYX pump...
9/18/2026
BreakingClinical TrialDeviceGlaucomaRegulationSurgical
US FDA Gives Green Light to Trial of Ciliatech’s Intercil Uveal Spacer for Glaucoma
France’s Ciliatech announced Sept. 8 that the US FDA had signed off on its investigational device exemption (IDE) submission, allowing the company to proceed with a feasibility study of its Interci...
9/18/2026
BreakingGene TherapyRegulationRetina
US FDA Accepts BLA for Nanoscope’s Optogenetic Gene Therapy Candidate in RP
Nanoscope Therapeutics announced Sept. 9 that the US FDA had accepted for review its biologics license application (BLA) for Mogenry, an optogenetic gene therapy candidate designed to restore visio...
9/18/2026
BreakingPharmaRegulationRetina
Surrozen Submits IND Application for Dual-Acting SZN-8141 in DME
Surrozen announced Sept. 8 that it had submitted an investigational new drug (IND) application to the US FDA to launch a clinical trial of SZN-8141, a bifunctional Wnt agonist and vascular endothel...
9/18/2026
BreakingChinaDealsGlaucomaPharmaRegulation
Chinese Regulators Accept NDA for Glaucoma Drop from Nicox, Ocumension
France’s Nicox and partner Ocumension Therapeutics, of China, announced Sept. 11 that China’s National Medical Products Administration (NMPA) had accepted the new drug application (NDA) for NCX 470...
9/18/2026
BreakingPharmaRegulationRetina
Belite Bio Submits NDA in Japan for Oral Tinlarebant in Stargardt
Belite Bio announced Sept. 8 that it had submitted a new drug application (NDA) for its oral Stargardt treatment candidate, tinlarebant, to Japan’s Ministry of Health, Labour, and Welfare. Tinlareb...
9/18/2026
BreakingFundingRetina
Foundation Fighting Blindness Renames Venture Arm as Gund Vision Fund
The Foundation Fighting Blindness, of Columbia, Maryland, reported Sept. 10 that it had renamed its venture philanthropy arm the Gund Vision Fund. The fund was formerly called the Retinal Degenerat...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.